These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23316936)

  • 1. Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS.
    Papisov MI; Belov VV; Gannon KS
    Mol Pharm; 2013 May; 10(5):1522-32. PubMed ID: 23316936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery.
    Pizzo ME; Wolak DJ; Kumar NN; Brunette E; Brunnquell CL; Hannocks MJ; Abbott NJ; Meyerand ME; Sorokin L; Stanimirovic DB; Thorne RG
    J Physiol; 2018 Feb; 596(3):445-475. PubMed ID: 29023798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion of macromolecules in the brain: implications for drug delivery.
    Wolak DJ; Thorne RG
    Mol Pharm; 2013 May; 10(5):1492-504. PubMed ID: 23298378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving mice.
    Nakajima T; Takeda S; Ito Y; Oyama A; Takami Y; Takeya Y; Yamamoto K; Sugimoto K; Shimizu H; Shimamura M; Rakugi H; Morishita R
    Fluids Barriers CNS; 2022 May; 19(1):31. PubMed ID: 35505336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: a mini review.
    Kuo A; Smith MT
    J Neurosci Methods; 2014 Aug; 233():166-71. PubMed ID: 24937765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS.
    Weller RO; Sharp MM; Christodoulides M; Carare RO; Møllgård K
    Acta Neuropathol; 2018 Mar; 135(3):363-385. PubMed ID: 29368214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal drug delivery in the era of nanomedicine.
    Fowler MJ; Cotter JD; Knight BE; Sevick-Muraca EM; Sandberg DI; Sirianni RW
    Adv Drug Deliv Rev; 2020; 165-166():77-95. PubMed ID: 32142739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
    Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?
    Abbott NJ; Pizzo ME; Preston JE; Janigro D; Thorne RG
    Acta Neuropathol; 2018 Mar; 135(3):387-407. PubMed ID: 29428972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.
    Vuillemenot BR; Korte S; Wright TL; Adams EL; Boyd RB; Butt MT
    Toxicol Sci; 2016 Jul; 152(1):3-9. PubMed ID: 27354708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
    Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
    Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
    Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
    CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human in silico trials for parametric computational fluid dynamics investigation of cerebrospinal fluid drug delivery: impact of injection location, injection protocol, and physiology.
    Khani M; Burla GKR; Sass LR; Arters ON; Xing T; Wu H; Martin BA
    Fluids Barriers CNS; 2022 Jan; 19(1):8. PubMed ID: 35090516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.
    Smith MW; Gumbleton M
    J Drug Target; 2006 May; 14(4):191-214. PubMed ID: 16777679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.